Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
PLoS Genet ; 7(6): e1002135, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21698133

RESUMEN

The N-Myc oncoprotein is a critical factor in neuroblastoma tumorigenesis which requires additional mechanisms converting a low-level to a high-level N-Myc expression. N-Myc protein is stabilized when phosphorylated at Serine 62 by phosphorylated ERK protein. Here we describe a novel positive feedback loop whereby N-Myc directly induced the transcription of the class III histone deacetylase SIRT1, which in turn increased N-Myc protein stability. SIRT1 binds to Myc Box I domain of N-Myc protein to form a novel transcriptional repressor complex at gene promoter of mitogen-activated protein kinase phosphatase 3 (MKP3), leading to transcriptional repression of MKP3, ERK protein phosphorylation, N-Myc protein phosphorylation at Serine 62, and N-Myc protein stabilization. Importantly, SIRT1 was up-regulated, MKP3 down-regulated, in pre-cancerous cells, and preventative treatment with the SIRT1 inhibitor Cambinol reduced tumorigenesis in TH-MYCN transgenic mice. Our data demonstrate the important roles of SIRT1 in N-Myc oncogenesis and SIRT1 inhibitors in the prevention and therapy of N-Myc-induced neuroblastoma.


Asunto(s)
Fosfatasa 6 de Especificidad Dual/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Proteínas Proto-Oncogénicas c-myc/metabolismo , Sirtuina 1/metabolismo , Animales , Sitios de Unión/genética , Línea Celular Tumoral , Proliferación Celular , Fosfatasa 6 de Especificidad Dual/genética , Inhibidores Enzimáticos/farmacología , Retroalimentación Fisiológica , Regulación Neoplásica de la Expresión Génica , Ratones , Ratones Transgénicos , Naftalenos/farmacología , Neuroblastoma/genética , Neuroblastoma/metabolismo , Neuroblastoma/patología , Fosforilación , Regiones Promotoras Genéticas , Estabilidad Proteica , Proteínas Proto-Oncogénicas c-myc/genética , Pirimidinonas/farmacología , Distribución Aleatoria , Sirtuina 1/genética , Factor de Transcripción Sp1/metabolismo , Carga Tumoral/efectos de los fármacos , Carga Tumoral/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA